London, Canada

Peter J Ferguson

This inventor holds 0 USPTO granted patents, plus 2 CIPO patents and 1 EPO patent.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter J Ferguson. Retrieved from https://idiyas.com/inventor/peter-j-ferguson-m7a644om

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...
Loading Chart...

Title: Innovations in Cancer Treatment by Peter J Ferguson

Introduction

Peter J Ferguson is a notable inventor based in London, Canada. He has made significant contributions to the field of cancer treatment through his innovative approaches. His work primarily focuses on methods that inhibit DNA repair proteins to enhance the effectiveness of cancer therapies.

Latest Patents

Peter J Ferguson holds a patent titled "Methods of Treating Cancer by Inhibition of DNA Repair Proteins." This patent outlines methods for treating cancer using antisense oligonucleotides directed against DNA double-strand break repair proteins such as BRCA2 or RAD51. The antisense oligonucleotides can be utilized alone or in combination with other cancer therapies, particularly those that induce DNA damage or inhibit DNA repair and synthesis. These therapies include radiation, platinum drugs, alkylating agents, PARP inhibitors, and inhibitors of thymidylate synthase. Notably, he currently has 0 patents registered.

Career Highlights

Peter J Ferguson is associated with Sarissa Inc., where he continues to develop innovative cancer treatment methods. His work is characterized by a commitment to advancing therapeutic strategies that can significantly impact patient outcomes.

Collaborations

Peter collaborates with talented individuals such as Mark Vincent and Mateusz Rytelewski. Their combined expertise contributes to the innovative research and development efforts at Sarissa Inc.

Conclusion

Peter J Ferguson's work in cancer treatment exemplifies the potential of innovative approaches to enhance therapeutic efficacy. His contributions to the field are paving the way for more effective cancer therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…